It was reported that after an alc procedure with an ultrabutton, the patient developed deep vein thrombosis.The condition was treated with medication (xarelto 15 mg and apixaban) twice per day via oral.The patient recovered successfully.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
|
H2, h3, h6: the reported device, used in treatment, was not returned for evaluation.A relationship, if any, between the subject device and the reported event could not be determined.A review of the device history records for the device showed there were no indications to suggest that the product did not meet manufacturing specification or would not be able to perform as intended.A complaint history review concluded this was a isolated issue.A review of risk management files found that the reported failure was documented appropriately.A review of the instructions for use found the potential complications associated with the use of this device.Clinical evaluation was completed and concluded that no relevant clinical information has been provided to perform a thorough medical investigation.Based on the information provided.This patient recovered after treatment with medication (xarelto 15 mg and apixaban) orally twice a day.Since no other harm has been alleged to this patient, no further clinical/medical assessment is warranted at this time.Without the reported product a visual and functional evaluation cannot be performed and customer¿s complaint cannot be confirmed.Factors that could have contributed to the reported event include: (1) potential complications accompanying such implant surgery.If the product associated with this event is returned at a future date, this evaluation will be reopened for investigation.
|